Entity Details

Primary name GLCNE_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9Y223
EntryNameGLCNE_HUMAN
FullNameBifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase
TaxID9606
Evidenceevidence at protein level
Length722
SequenceStatuscomplete
DateCreated2004-03-15
DateModified2021-06-02

Ontological Relatives

GenesGNE

GO terms

Show/Hide Table
GOName
GO:0004553 hydrolase activity, hydrolyzing O-glycosyl compounds
GO:0005524 ATP binding
GO:0005737 cytoplasm
GO:0005829 cytosol
GO:0006045 N-acetylglucosamine biosynthetic process
GO:0006047 UDP-N-acetylglucosamine metabolic process
GO:0006054 N-acetylneuraminate metabolic process
GO:0007155 cell adhesion
GO:0008761 UDP-N-acetylglucosamine 2-epimerase activity
GO:0009384 N-acylmannosamine kinase activity
GO:0046872 metal ion binding

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm

Domains

Show/Hide Table
DomainNameCategoryType
IPR000600 ROK familyFamilyFamily
IPR003331 UDP-N-acetylglucosamine 2-epimerase domainDomainDomain
IPR020004 UDP-N-acetylglucosamine 2-epimerase,UDP-hydrolysingFamilyFamily
IPR043129 ATPase, nucleotide binding domainFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
269921 OMIMSialuria (SIALURIA)In sialuria, free sialic acid accumulates in the cytoplasm and gram quantities of neuraminic acid are secreted in the urine. The metabolic defect involves lack of feedback inhibition of UDP-GlcNAc 2-epimerase by CMP-Neu5Ac, resulting in constitutive overproduction of free Neu5Ac. Clinical features include variable degrees of developmental delay, coarse facial features and hepatomegaly. Sialuria inheritance is autosomal dominant. The disease is caused by variants affecting the gene represented in this entry.
605820 OMIMNonaka myopathy (NM)Autosomal recessive muscular disorder, allelic to inclusion body myopathy 2. It is characterized by weakness of the anterior compartment of the lower limbs with onset in early adulthood, and sparing of the quadriceps muscles. As the inclusion body myopathy, NM is histologically characterized by the presence of numerous rimmed vacuoles without inflammatory changes in muscle specimens. The disease is caused by variants affecting the gene represented in this entry.

Interactions

67 interactions

InteractorPartnerSourcesPublicationsLink
GLCNE_HUMANSPY2_HUMANBioGRID, IntAct25416956 details
GLCNE_HUMANKRA59_HUMANBioGRID, IntAct25416956 32296183 details
GLCNE_HUMANKR105_HUMANIntAct25416956 details
GLCNE_HUMANKR107_HUMANBioGRID, IntAct25416956 32296183 details
GLCNE_HUMANKR108_HUMANBioGRID, IntAct25416956 32296183 details
GLCNE_HUMANKR109_HUMANBioGRID, IntAct25416956 details
GLCNE_HUMANK1H1_HUMANBioGRID, IntAct25416956 32296183 details
GLCNE_HUMANATL4_HUMANBioGRID, IntAct25416956 32296183 details
GLCNE_HUMANNT2NA_HUMANBioGRID, IntAct25416956 31515488 32296183 details
GLCNE_HUMANGTPB3_HUMANBioGRID, IntAct25416956 details
GLCNE_HUMANKR412_HUMANBioGRID, IntAct25416956 details
GLCNE_HUMANKRA92_HUMANBioGRID, IntAct25416956 32296183 details
GLCNE_HUMANGLCNE_HUMANBioGRID, IntAct25416956 details
GLCNE_HUMANCRTP1_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANTRI27_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKRA98_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANNT2NC_HUMANBioGRID, IntAct25416956 32296183 details
GLCNE_HUMANTRIP6_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKRT34_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANHXA1_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKRA33_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKR171_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKRT83_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANWDR83_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANWWOX_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKR192_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANCV039_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANEGFL7_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANSPY3_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANGRN_HUMANBioGRID, IntAct32296183 32814053 details
GLCNE_HUMANKRA62_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKR197_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANK1C40_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKRA11_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKRA93_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANMDFI_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKRA44_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKR123_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKPRP_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKRA31_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANSPY1_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKRT86_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANTRI42_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANPROP_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANTSN4_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANVWC2_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKR411_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKR132_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKRT85_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANPA2GX_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKRA61_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKR111_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANECM1_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANKR133_HUMANBioGRID, IntAct32296183 details
GLCNE_HUMANACTN1_HUMANIntAct18560563 details
GLCNE_HUMANWFS1_HUMANIntAct32814053 details
GLCNE_HUMANKR103_HUMANBioGRID25416956 details
GLCNE_HUMANNID2_HUMANBioGRID32296183 details
GLCNE_HUMANPRIC4_HUMANBioGRID32296183 details
GLCNE_HUMANSRB4D_HUMANBioGRID32296183 details
GLCNE_HUMANMGT5B_HUMANBioGRID32296183 details
GLCNE_HUMANKRA41_HUMANBioGRID32296183 details
GLCNE_HUMANKRA13_HUMANBioGRID32296183 details
GLCNE_HUMANZBT16_HUMANHPRD17118363 details
GLCNE_HUMANRIF1_HUMANHPRD17118363 details
GLCNE_HUMANDPYL1_HUMANHPRD17118363 details
GLCNE_HUMANK1549_HUMANHPRD17118363 details